These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 19349986)

  • 41. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.
    Zhan Y; Carrington EM; van Nieuwenhuijze A; Bedoui S; Seah S; Xu Y; Wang N; Mintern JD; Villadangos JA; Wicks IP; Lew AM
    Eur J Immunol; 2011 Sep; 41(9):2585-95. PubMed ID: 21660938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Teleost Skin CD8α+ Dendritic-like Cells, Representing a Potential Common Ancestor for Mammalian Cross-Presenting Dendritic Cells.
    Granja AG; Leal E; Pignatelli J; Castro R; Abós B; Kato G; Fischer U; Tafalla C
    J Immunol; 2015 Aug; 195(4):1825-37. PubMed ID: 26179908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses.
    Semmrich M; Plantinga M; Svensson-Frej M; Uronen-Hansson H; Gustafsson T; Mowat AM; Yrlid U; Lambrecht BN; Agace WW
    Mucosal Immunol; 2012 Mar; 5(2):150-60. PubMed ID: 22166938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.
    Mackay LK; Rahimpour A; Ma JZ; Collins N; Stock AT; Hafon ML; Vega-Ramos J; Lauzurica P; Mueller SN; Stefanovic T; Tscharke DC; Heath WR; Inouye M; Carbone FR; Gebhardt T
    Nat Immunol; 2013 Dec; 14(12):1294-301. PubMed ID: 24162776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimal effect of CD103 expression on the control of a chronic antiviral immune response.
    Fousteri G; Dave A; Juntti T; Morin B; McClure M; Von Herrath M
    Viral Immunol; 2010 Jun; 23(3):285-94. PubMed ID: 20565292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
    Schreibelt G; Klinkenberg LJ; Cruz LJ; Tacken PJ; Tel J; Kreutz M; Adema GJ; Brown GD; Figdor CG; de Vries IJ
    Blood; 2012 Mar; 119(10):2284-92. PubMed ID: 22234694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells.
    Bougnères L; Helft J; Tiwari S; Vargas P; Chang BH; Chan L; Campisi L; Lauvau G; Hugues S; Kumar P; Kamphorst AO; Dumenil AM; Nussenzweig M; MacMicking JD; Amigorena S; Guermonprez P
    Immunity; 2009 Aug; 31(2):232-44. PubMed ID: 19699172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional and Functional Analysis of CD1c
    Bourdely P; Anselmi G; Vaivode K; Ramos RN; Missolo-Koussou Y; Hidalgo S; Tosselo J; Nuñez N; Richer W; Vincent-Salomon A; Saxena A; Wood K; Lladser A; Piaggio E; Helft J; Guermonprez P
    Immunity; 2020 Aug; 53(2):335-352.e8. PubMed ID: 32610077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.
    Cohn L; Chatterjee B; Esselborn F; Smed-Sörensen A; Nakamura N; Chalouni C; Lee BC; Vandlen R; Keler T; Lauer P; Brockstedt D; Mellman I; Delamarre L
    J Exp Med; 2013 May; 210(5):1049-63. PubMed ID: 23569326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD11b+ migratory dendritic cells mediate CD8 T cell cross-priming and cutaneous imprinting after topical immunization.
    Nizza ST; Campbell JJ
    PLoS One; 2014; 9(3):e91054. PubMed ID: 24618819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.
    Allan RS; Waithman J; Bedoui S; Jones CM; Villadangos JA; Zhan Y; Lew AM; Shortman K; Heath WR; Carbone FR
    Immunity; 2006 Jul; 25(1):153-62. PubMed ID: 16860764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses.
    Kim TS; Braciale TJ
    PLoS One; 2009; 4(1):e4204. PubMed ID: 19145246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct APC subtypes drive spatially segregated CD4+ and CD8+ T-cell effector activity during skin infection with HSV-1.
    Macleod BL; Bedoui S; Hor JL; Mueller SN; Russell TA; Hollett NA; Heath WR; Tscharke DC; Brooks AG; Gebhardt T
    PLoS Pathog; 2014 Aug; 10(8):e1004303. PubMed ID: 25121482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inclusion of Brefeldin A during dendritic cell isolation allows in vitro detection of cross-presented self-antigens.
    Benke D; Krüger T; Lang A; Hamilton-Williams EE; Kurts C
    J Immunol Methods; 2006 Mar; 310(1-2):12-9. PubMed ID: 16510151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.